Immortal human ovary carcinoma cell strain and its establishment method
A method and technology for establishing ovarian cancer, applied in the field of immortalized cell lines of human ovarian sarcoma-like carcinoma, to achieve the effects of high line formation efficiency, high malignancy, and enrichment of in vitro cell banks
- Summary
 - Abstract
 - Description
 - Claims
 - Application Information
 
 AI Technical Summary 
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0038] One, the construction of SV40 gene eukaryotic expression vector
[0039] pS 3 neo contains SV40 T antigen (including large T and small T antigen) gene fragments, which can be digested with BamH I to obtain a 3kb SV40 T gene fragment, which is recovered by electrophoresis. pcD2 is a high-efficiency expression eukaryotic vector plasmid, which is digested with BamH I at the multiple cloning site, and the linear vector is recovered by electrophoresis, and then treated with calf intestinal alkaline phosphatase to prevent self-ligation. Ligate it with the recovered SV40 T gene fragment under the action of T4 DNA ligase to obtain the recombinant plasmid pcD2-SV40. Recombinant plasmids were identified by enzyme digestion. The positive clone of pcD2-SV40 was screened out by SmaI and HpaI double digestion. The pSV 3 Both neo and pcD2 were donated by Dr. Li Huiping, Institute of Hematology, Peking University People's Hospital.
[0040] 2. Primary culture of human ovarian sarc...
PUM
 Login to View More Abstract
Description
Claims
Application Information
 Login to View More - R&D
 - Intellectual Property
 - Life Sciences
 - Materials
 - Tech Scout
 
- Unparalleled Data Quality
 - Higher Quality Content
 - 60% Fewer Hallucinations
 
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
